• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • GPs

GP Profile: Lion Capital

Lyndon Lea of Lion Capital
Lyndon Lea, Lion Capital
  • Denise Ko Genovese
  • Denise Ko Genovese
  • 02 May 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Currently raising Lion Capital IV with $2.25bn target
  • Over 100 consumer brands acquired to date
  • Lyndon Lea and Robert Darwent set up the firm in 2004 together with Neil Richardson
  • Offices in London and Los Angeles

 

Lion Capital founder and managing partner Lyndon Lea talks to Denise Ko Genovese about the genesis of the GP and challenges in the ever-changing retail landscape

Click here to view a complete profile of Lion Capital, including details of funds, LPs and investments on unquote" data

"We all have great elevator pitches about how we add value but the reality is, it's very competitive these days and you are frequently getting beaten in competitive processes," says Lion Capital founding partner Lyndon Lea. "There were loads of generalist funds back when we started and we were one of the first to be sector-focused. But that's not a unique position anymore."

The London-headquartered GP began life in 2004 when Lyndon Lea, Robert Darwent and Neil Richardson set up Lion Capital. The private equity house has since become synonymous with some of the most well-known consumer brands in the market such as Weetabix, Orangina-Schweppes, Jimmy Choo, Wagamama, Kettle Foods and AllSaints, having invested in around 30 businesses incorporating more than 100 consumer brands.

Lion Capital Partners' investment activity by region

Lion is currently raising its fourth fund – Lion Capital 2015 – from which it has already made two investments: protein bar maker Grenade in March this year and casual dining and bar chain Loungers in December 2016. The target is thought to be in the $2.25bn region with a first close already touted in the $1bn range last December.

Previous funds include Lion Capital Fund I, which closed on €820m in 2004; Lion Capital Fund II, which closed on €2bn in 2007; and Lion Capital Fund III, which closed on €1.5bn in 2010. They are all fully deployed.

Less is more
With the proliferation of funds, buoyancy of markets and increasingly liquid debt markets, competition has spiked for everyone in recent years, says Lea. But while some big private equity firms are getting bigger and diversifying into other areas, Lion is determined to stay on the same path.

"I think we will extrapolate our original thesis – focus on less – but take it even further than we have in the past," says Lea, adding that there is no temptation to become more generalist. "Perhaps we'll focus our capital on doing fewer investments with more conviction. It is difficult to find 11-12 deals to put in a fund these days."

Lion Capital Partners' investment activity

Lea admits that it is hard to know where Lion or the private equity world in general will evolve to next, let alone retail and consumer trends.

"The retail environment terrifies me. Everyone is talking about experience versus product and what the millennial customer wants, but I don't think it is quite as simple as that. We have to understand what experience is being sought and why. Things are in a state of flux and it is difficult to know what the vision of retail will be like in 5-10 years' time."

But Lion is clearly undeterred by the ever-changing consumer landscape. Perhaps because the team has made a success of it for so long.

"There are brands and there are brands," says Lea. "The moment of truth comes when you go to a shop and Weetabix – or the product you are seeking – isn't on the shelf. What do you do?" he asks. "Very few products pass this test. Orangina and Coca-Cola do because you don't settle for a substitute product." 

You know when it is time to call it a day when the incremental capital needed doesn't offer the rates of return you need. We have the scars on our back. We have made mistakes" – Lyndon Lea, Lion Capital

Presumably it was that brand test that caught Lion's eye when first investing in Weetabix in 2004.

"It was third-generation family-owned and we had a very candid conversation with Richard George who was running the show at the time. He said he wasn't the guy to take it to the next level, so we changed all the management team apart from the CFO."

Despite already being a household name and deeply embedded into the UK consumer psyche, the GP's introduction of new products alone increased turnover by £250m, with EBITDA growing to £128m just before its 60% partial exit in 2012, up from £67m on entry in 2005.

It is not just profit-making businesses with a need to diversify that Lion is attracted to. Contemporary fashion brand AllSaints was 24 hours away from administration when the GP struck a deal in 2011. Lion acquired the business together with US partner Goode for £105m and sales are now £350m a year compared to £200m, with the company turning a profit of £28m.

"In this case it was about educating the customer that they couldn't always buy on discount. But everyone wants value, even in luxury."

Calling it a day
Even the consumer specialist whose other successes include hair styling products group GHD and noodle chain Wagamama are not immune to errors, with the group very candid about the letting go of investments such as lingerie business La Senza, frozen food group Findus and personal care company Personna.

"You know when it is time to call it a day when the incremental capital needed doesn't offer the rates of return you need," says Lea. "We have the scars on our back. We have made mistakes." But what does resonate with founders of ­companies is that Lion has been doing this for a long time, Lea says.

"We have a great knack of taking businesses from the $50-100m bracket to the $200m-plus bracket. But they are getting harder to find," he admits.

"Before you could buy a business and within two to three years make a return. That has changed and now the depth and scale of change needs to be greater. The market is heading towards longer holding periods for investments," he says, adding that almost all of Lion's 2010 investments are still under its ownership.

"Previously, a typical holding time was three to fours years before exiting, but now it seems the market is heading towards six-plus. Perhaps the traditional 10-year fund model needs a rethink."

Key People

• Lyndon Lea, founder and managing partner, was previously a partner of Hicks Muse Tate & Furst where he co-founded its European operations in 1998. Prior to this, he was at Glenisla, the European affiliate of KKR.
• Robert Darwent, partner, was previously at Hicks Muse Tate & Fust and also in the private equity group of Morgan Stanley in London.
• Javier Ferran, partner, was previously at the Bacardi Group for 20 years, which included the role of president and CEO of Bacardi.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • GPs
  • Top story
  • In Profile
  • Lion Capital
  • Retail & consumer

More on GPs

EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
Canary Wharf and the financial centre of London
IPO offers CVC chance to become multi-asset consolidator

Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl

  • GPs
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013